STRONATI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 817
EU - Europa 399
AS - Asia 123
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
AF - Africa 1
Totale 1.347
Nazione #
US - Stati Uniti d'America 749
GB - Regno Unito 132
SE - Svezia 110
CA - Canada 68
CN - Cina 68
DE - Germania 40
IT - Italia 29
FI - Finlandia 28
BE - Belgio 19
RU - Federazione Russa 19
HK - Hong Kong 16
FR - Francia 15
KR - Corea 9
IN - India 6
JP - Giappone 6
SG - Singapore 5
IR - Iran 4
MO - Macao, regione amministrativa speciale della Cina 4
BR - Brasile 3
RO - Romania 3
VN - Vietnam 3
AU - Australia 2
EU - Europa 2
HU - Ungheria 2
EG - Egitto 1
IE - Irlanda 1
MY - Malesia 1
PL - Polonia 1
TW - Taiwan 1
Totale 1.347
Città #
Chandler 287
San Mateo 69
Toronto 68
Southend 64
Ashburn 59
New York 39
Beijing 26
Helsinki 26
Boardman 25
Berlin 23
Brussels 19
Ann Arbor 18
Hong Kong 14
Marseille 13
Trenton 13
Las Vegas 11
Redwood City 10
Rome 10
Los Angeles 9
Mountain View 8
Dongguan 7
Pontedera 5
Falls Church 4
Guangzhou 4
Miami 4
Wilmington 4
Zhengzhou 4
Iasi 3
Nogara 3
Shanghai 3
Singapore 3
Bangalore 2
Bengaluru 2
Boa Vista 2
Budapest 2
Catanzaro 2
Central District 2
Dong Ket 2
Fars 2
Honolulu 2
Lappeenranta 2
Morcone 2
Namdong-gu 2
Rozzano 2
San Jose 2
Tokyo 2
Washington 2
Aberdeen 1
Albuquerque 1
Brooklyn 1
Cambridge 1
Dallas 1
Delhi 1
Detroit 1
Hanoi 1
Hanover 1
Hartford 1
Hefei 1
London 1
Mazzano Romano 1
Melbourne 1
Milan 1
Nedlands 1
Norwalk 1
Pozzuoli 1
Providence 1
Redmond 1
Rostov-on-Don 1
Seattle 1
South San Francisco 1
St Petersburg 1
Taipei 1
Taubaté 1
Tehran 1
Yao 1
Totale 915
Nome #
Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data 80
Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in Mice 76
Dipotassium glycyrrhizate via HMGB1 or AMPK signaling suppresses oxidative stress during intestinal inflammation 71
Lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn's disease 65
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase 65
Lactobacillus reuteri ATCC55730 in cystic fibrosis 64
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes 61
Apoptosis, necrosis, and necroptosis in the gut and intestinal homeostasis 59
Endoplasmic reticulum stress and unfolded protein response are involved in paediatric inflammatory bowel disease 59
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease 58
Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines 57
NOD2 Is Regulated by MIR-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease 55
Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation 54
Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway 53
Krill oil reduces intestinal inflammation by improving epithelial integrity and impairing adherent-invasive Escherichia coli pathogenicity 52
Necroptosis in intestinal inflammation and cancer: New concepts and therapeutic perspectives 51
Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease 50
Advances in the medical management of paediatric IBD 50
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease 49
Intestinal Inflammation Alters the Expression of Hepatic Bile Acid Receptors Causing Liver Impairment 48
Functional analysis of gut microbiota and immunoinflammation in children with autism spectrum disorders 47
Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease 46
Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach 45
Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates 29
ZNF281 Promotes Colon Fibroblast Activation in TGFβ1-Induced Gut Fibrosis 17
Totale 1.361
Categoria #
all - tutte 9.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.822


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202033 0 0 0 1 5 2 6 8 4 5 1 1
2020/2021186 2 3 3 2 44 6 7 23 3 7 74 12
2021/2022268 10 71 5 14 43 8 7 67 7 6 13 17
2022/2023547 31 108 37 85 17 106 1 51 85 14 6 6
2023/2024326 15 11 38 8 20 85 18 55 30 7 15 24
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 1.361